Center-Authored Papers
Filters: Keyword is Granulocyte Colony-Stimulating Factor [Clear All Filters]
Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.. Critical reviews in oncology/hematology. 74(3):203-10. Abstract
.
2010.
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.. European journal of cancer (Oxford, England : 1990). 42(15):2433-53. Abstract
.
2006.
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.. European journal of cancer (Oxford, England : 1990). 47(1):8-32. Abstract
.
2011.
G-CSF as prophylaxis of febrile neutropenia in SCLC.. Expert opinion on pharmacotherapy. 3(9):1273-81. Abstract
.
2002.
Interactive discussion on chemotherapy-related adverse events.. Pharmacotherapy. 20(7 Pt 2):121S-125S.
.
2000.
Management of chemotherapy in a pregnancy complicated by a large neuroblastoma.. Obstetrics and gynecology. 84(4 Pt 2):665-8. Abstract
.
1994.
Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(5):1583-5.
.
2001.
Allogeneic transplantation: peripheral blood vs. bone marrow.. Current opinion in oncology. 24(2):191-196. Abstract
.
2012.
.
1996.
.
2008.
Colony stimulating factors for chemotherapy induced febrile neutropenia.. The Cochrane database of systematic reviews. (3):CD003039. Abstract
.
2003.
.
2007.
Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
.
2009.
Myeloid growth factors clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 3(4):540-55.
.
2005.
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.. The New England journal of medicine. 325(3):164-70. Abstract
.
1991.
.
2010.
Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
.
2008.
.
2008.
.
2012.
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.. PharmacoEconomics. 30(6):497-511. Abstract
.
2012.
Agents under investigation for the treatment and prevention of neutropenia.. Expert opinion on investigational drugs. 16(11):1831-40. Abstract
.
2007.
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
.
2011.
.
1999.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.. Molecular & cellular proteomics : MCP. 11(6):M111.013854. Abstract
.
2012. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)